Novozymes and Chr. Hansen agree deal to merge
December 12, 2022 at 03:08 AM EST
The Danish companies will create a biological solutions provider with combined annual revenue of around 3.5 billion euros ($3.69 billion).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|